Market Research Logo

Global Nuclear Medicine Radioisotope Market - Segmented by Type of Power Source, Product, and Application - Growth, Trends, and Forecast (2018 - 2023)

Global Nuclear Medicine Radioisotope Market - Segmented by Type of Power Source, Product, and Application - Growth, Trends, and Forecast (2018 - 2023)

The global nuclear medicine radioisotope market was valued at USD 13.9 billion in 2017, and is expected to register a CAGR of 12.3% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 40% of the global market, in 2017, whereas, Asia-Pacific is anticipated to register the highest CAGR over the forecast period.

Rising SPECT and PET Applications

The field of nuclear medicine is dominated by the applications related to positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). The growing interest of PET technology in cardiac and neurological disorders is expected to fuel the market’s growth. More than 60% of SPECT procedures are performed in cardiology. In addition, orthopedics, oncology, and infection imaging are emerging as areas that can benefit from the same. Applications have been further increasing, through the inclusion of advancements in computed tomography (CT), making nuclear medicine the right choice for disease diagnosis. In addition, factors, such as rising incidences of cardiac and cancer cases, along with the rising awareness among the public, drive the nuclear medicine market.

High Capital Investments Involved

One of the major hindrance for the nuclear medicine radioisotope market is the high capital investments required for the generation of radionuclide. Cyclotron initial investment is very high, which is followed by renovation and installation. Further, annual operating costs are involved. With high investment, the cost of imaging and treatment becomes a factor of high expenditure, especially in developing markets. These factors, and unclear regulatory guidelines, varied reimbursement policies, and short half-life of radiopharmaceuticals restrict the growth of the market studied.

North America to Dominate the Market

The global nuclear medicine radioisotope market has been segmented by type of radioisotope, application in different indications, and geography. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.

North America dominated the nuclear medicine radioisotope market, with a share of 40%, in 2017. The factors, such as well-established healthcare facilities, growing geriatric population, rising awareness among people for nuclear medicine treatments and diagnosis, contribute to the growth of the regional market. Moreover, Asia-Pacific is estimated to register the highest CAGR during the forecast period.

Key Developments in the Market

  • December 2017: Caris Life Sciences identified a new mechanism for the treatment of non-Hodgkin lymphoma (NHL), using a single-stranded DNA aptamer, C10.36, specifically binding to heterogeneous nuclear ribonucleoprotein U (hnRNP U)
  • October 2017: Siemens Healthcare introduced biograph vision PET/CT system, a software platform at the 30th Annual Congress of the European Association of Nuclear Medicine (EANM), to provide a new level of precision in PET/CT imaging.

Reasons to Purchase This Report
  • Analysis of the global nuclear medicine radioisotope market, with region-specific assessments and competition analysis, on global and regional scales.
  • Analyzing various perspectives of the industry with the help of Porter’s five forces analysis.
  • The treatment type that is expected to dominate the market.
  • Regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet (in excel).
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Degree of Competition
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Incidences of Cancer and Cardiac Disorders
6.1.2 Widening Applications of Nuclear Medicine
6.1.3 Increasing SPECT and PET Applications
6.1.4 Increasing Patient Awareness for Healthcare
6.2 Market Restraints
6.2.1 Reimbursement Complications
6.2.2 Regulatory Issues
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Radioisotope
7.1.1 Technetium-99m (Tc-99m)
7.1.2 Thallium-201 (Tl-201)
7.1.3 Iodine (I-123)
7.1.4 Gallium-67 (Ga-67)
7.1.5 Fluorine-18
7.1.6 Rubidium-82 (Rb-82)
7.1.7 Other Types of Radioisotope
7.2 By Application
7.2.1 Oncology
7.2.2 Cardiology
7.2.3 Lymphoma
7.2.4 Thyroid
7.2.5 Neurology
7.2.6 Others
7.3 By Geography
7.3.1 North America United States Canada Mexico
7.3.2 Europe United Kingdom Germany France Italy Spain Rest of Europe
7.3.3 Asia-Pacific India China Japan Rest of Asia-Pacific
7.3.4 Rest of the World
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Agfa-Gevaert Group
9.2 Braco
9.3 Cardiarc Ltd
9.4 Cardinal Health Inc.
9.5 CMR Naviscan (Gamma Medica Inc.)
9.6 Curium
9.7 Digirad Corporation
9.8 GE Healthcare
9.9 Nordion (Canada) Inc.
9.10 NTP Radioisotopes SOC Ltd
9.11 Positron Corp.
9.12 Segami Corporation
9.13 Siemens Healthcare
10. Future Outlook of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report